Lv1
10 积分 2025-05-13 加入
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
5个月前
已完结
Gastric cancer
5个月前
已完结
Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy
5个月前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
5个月前
已完结
Geroscience
7个月前
已完结
From geroscience to precision geromedicine: Understanding and managing aging
7个月前
已完结
ESPEN Guideline on clinical nutrition in surgery – Update 2025
7个月前
已完结
Identification of Bile Survivin and Carbohydrate Antigen 199 in Distinguishing Cholangiocarcinoma from Benign Obstructive Jaundice
8个月前
已关闭
皖公网安备34019202002308
